The nuclear export protein exportin-1 in solid malignant tumours: From biology to clinical trials.

Clin Transl Med · 2024 · PMC11116501 · PMID 38783482

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Of the eight patients who could be evaluated, 50% had SD, 25% had PR and some had a decreasing trend in prostate‐specific antigen (PSA) levels after selinexor treatment.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.